HALO logo

Halozyme Therapeutics (HALO) Operating Margin

HALO Annual Operating Margin

40.71%
+0.18%+0.44%

31 December 2023

HALO Operating Margin Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

HALO Quarterly Operating Margin

56.26%
+5.59%+11.03%

30 September 2024

HALO Quarterly Operating Margin Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

HALO Operating Margin Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+0.4%+37.7%
3 y3 years-24.5%+37.7%
5 y5 years+189.2%+37.7%

HALO Operating Margin High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-34.6%+0.4%-12.8%+151.7%
5 y5-year-34.6%+218.0%-17.5%+194.2%
alltimeall time-34.6%+100.4%-17.5%+100.4%

Halozyme Therapeutics Operating Margin History

DateAnnualQuarterly
Sept 2024
-
56.26%(+11.0%)
June 2024
-
50.67%(+3.9%)
Mar 2024
-
48.78%(+11.1%)
Dec 2023
40.71%(+0.4%)
43.92%(+7.5%)
Sept 2023
-
40.86%(-4.4%)
June 2023
-
42.73%(+28.8%)
Mar 2023
-
33.18%(-19.2%)
Dec 2022
40.53%(-34.9%)
41.05%(+3.0%)
Sept 2022
-
39.86%(+78.3%)
June 2022
-
22.35%(-65.4%)
Mar 2022
-
64.52%(+16.4%)
Dec 2021
62.24%(+15.5%)
55.42%(-15.1%)
Sept 2021
-
65.26%(-4.3%)
June 2021
-
68.19%(+19.7%)
Mar 2021
-
56.99%(-10.6%)
Dec 2020
53.91%(-256.3%)
63.78%(+3.4%)
Sept 2020
-
61.70%(+15.3%)
June 2020
-
53.52%(-521.1%)
Mar 2020
-
-12.71%(-78.7%)
Dec 2019
-34.50%(-24.4%)
-59.74%(+12.5%)
Sept 2019
-
-53.08%(+48.7%)
June 2019
-
-35.70%(-785.2%)
Mar 2019
-
5.21%(-4441.7%)
Dec 2018
-45.65%(-278.5%)
-0.12%(-99.9%)
Sept 2018
-
-99.68%(+74.8%)
June 2018
-
-57.02%(-25.8%)
Mar 2018
-
-76.81%(-215.6%)
Dec 2017
25.58%(-145.1%)
66.43%(+424.3%)
Sept 2017
-
12.67%(-116.8%)
June 2017
-
-75.49%(-18.9%)
Mar 2017
-
-93.09%(+60.8%)
Dec 2016
-56.72%(+179.0%)
-57.88%(-18.9%)
Sept 2016
-
-71.40%(+9.6%)
June 2016
-
-65.16%(+71.2%)
Mar 2016
-
-38.05%(-463.8%)
Dec 2015
-20.33%(-75.7%)
10.46%(-109.4%)
Sept 2015
-
-111.82%(-1246.9%)
June 2015
-
9.75%(-113.1%)
Mar 2015
-
-74.53%(+487.8%)
Dec 2014
-83.68%
-12.68%(-90.3%)
Sept 2014
-
-130.26%(+60.3%)
DateAnnualQuarterly
June 2014
-
-81.26%(-61.4%)
Mar 2014
-
-210.76%(+23.5%)
Dec 2013
-146.78%(+15.8%)
-170.62%(+47.7%)
Sept 2013
-
-115.49%(-24.5%)
June 2013
-
-153.04%(-2.1%)
Mar 2013
-
-156.29%(+672.9%)
Dec 2012
-126.70%(+258.2%)
-20.22%(-94.6%)
Sept 2012
-
-375.49%(+107.3%)
June 2012
-
-181.10%(-11.0%)
Mar 2012
-
-203.50%(-73.4%)
Dec 2011
-35.37%(-91.1%)
-764.28%(-3502.8%)
Sept 2011
-
22.46%(+68.2%)
June 2011
-
13.35%(-110.4%)
Mar 2011
-
-128.05%(-74.4%)
Dec 2010
-398.25%(-6.9%)
-500.59%(+36.7%)
Sept 2010
-
-366.07%(-3.2%)
June 2010
-
-378.17%(+10.4%)
Mar 2010
-
-342.51%(+74.1%)
Dec 2009
-427.60%(-25.7%)
-196.72%(-57.3%)
Sept 2009
-
-460.22%(-61.6%)
June 2009
-
-1197.89%(+125.0%)
Mar 2009
-
-532.35%(-4.3%)
Dec 2008
-575.47%(-22.3%)
-556.04%(+22.2%)
Sept 2008
-
-454.86%(-42.6%)
June 2008
-
-793.08%(+32.2%)
Mar 2008
-
-600.02%(-19.1%)
Dec 2007
-740.89%(-53.3%)
-742.01%(-15.8%)
Sept 2007
-
-881.30%(+7.1%)
June 2007
-
-823.23%(+63.5%)
Mar 2007
-
-503.62%(-54.0%)
Dec 2006
-1587.26%(-85.1%)
-1095.13%(+3.8%)
Sept 2006
-
-1055.53%(-63.0%)
June 2006
-
-2853.85%(-43.1%)
Mar 2006
-
-5012.27%(-21.8%)
Dec 2005
-10.66 K%(+6527.8%)
-6406.95%(-56.4%)
Sept 2005
-
-14.68 K%(+127.8%)
June 2005
-
-6445.22%(>+9900.0%)
Dec 2002
-
-34.67%(-54.0%)
Sept 2002
-
-75.32%(-67.7%)
June 2002
-
-233.47%(-645.4%)
Mar 2002
-
42.81%
Dec 2001
-160.85%
-

FAQ

  • What is Halozyme Therapeutics annual operating profit margin?
  • What is the all time high annual operating margin for Halozyme Therapeutics?
  • What is Halozyme Therapeutics annual operating margin year-on-year change?
  • What is Halozyme Therapeutics quarterly operating profit margin?
  • What is the all time high quarterly operating margin for Halozyme Therapeutics?
  • What is Halozyme Therapeutics quarterly operating margin year-on-year change?

What is Halozyme Therapeutics annual operating profit margin?

The current annual operating margin of HALO is 40.71%

What is the all time high annual operating margin for Halozyme Therapeutics?

Halozyme Therapeutics all-time high annual operating profit margin is 62.24%

What is Halozyme Therapeutics annual operating margin year-on-year change?

Over the past year, HALO annual operating profit margin has changed by +0.18% (+0.44%)

What is Halozyme Therapeutics quarterly operating profit margin?

The current quarterly operating margin of HALO is 56.26%

What is the all time high quarterly operating margin for Halozyme Therapeutics?

Halozyme Therapeutics all-time high quarterly operating profit margin is 68.19%

What is Halozyme Therapeutics quarterly operating margin year-on-year change?

Over the past year, HALO quarterly operating profit margin has changed by +15.40% (+37.69%)